Neutral Aurobindo Pharma; target of Rs 500: Motilal Oswal

Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 500 in its research report dated November 14, 2022.

Loan Amount?: Number of Months? (#): Annual Interest Rate?: Payment Method?:

Monthly Payment: Total Interest: Total Principal & Interest:

Original Size

Periodic Savings Amount?: Number of Months?: Annual Interest Rate?:

Final Amount (future value): Interest Earned: Total Amount Invested: Last Deposit Date:

Original Size

Your Current Age?: Anticipated Retirement Age?: Current Retirement Savings?: Annual Interest Rate (ROR)?: Amount At Retirement?:

Monthly Investment Required: Number of Contributions: Total Amount Invested: Interest Earned: Estimated Final Value: Last Deposit Date:

Original Size

Your Current Age?: Anticipated Retirement Age?: Current Retirement Savings?: Monthly Amount Invested?: Annual Interest Rate (ROR)?:

Available At Retirement: Number of Contributions: Total Amount Invested: Return on Investment: Last Investment Date:

Original Size

Your Current Age?: Current Retirement Savings?: Monthly Amount Invested?: Annual Interest Rate (ROR)?: Amount At Retirement?:

Projected Retirement Age: Number of Contributions (#): Total Amount Invested: Investment Gain: Estimated Final Value: Last Deposit Date:

Original Size

प्रातिक्रिया दे जवाब रद्द करें